Assignee
XOMA CORP
US·140 granted patents·7 pending applications·10,648 citations·filing 1982–2016
Top patents by PatentIndex Score
147 records- 0199US5500362AChimeric antibody with specificity to human B cell surface antigenXOMA CORP·Filed 1991·Granted Mar 19, 1996·2.8k cites·9 claims
- 0298US5721108AChimeric antibody with specificity to human B cell surface antigenXOMA CORP·Filed 1995·Granted Feb 24, 1998·269 cites·25 claims
- 0398US5698417AModular assembly of antibody genes, antibodies prepared thereby and useXOMA CORP·Filed 1995·Granted Dec 16, 1997·272 cites·17 claims
- 0498US5693493AModular assembly of antibody genes, antibodies prepared thereby and useXOMA CORP·Filed 1995·Granted Dec 2, 1997·272 cites·9 claims
- 0598US5677180AChimeric antibody with specificity to human B cell surface antigenXOMA CORP·Filed 1995·Granted Oct 14, 1997·316 cites·12 claims
- 0698US5618920AModular assembly of antibody genes, antibodies prepared thereby and useXOMA CORP·Filed 1994·Granted Apr 8, 1997·562 cites·45 claims
- 0798US5576195AVectors with pectate lyase signal sequenceXOMA CORP·Filed 1994·Granted Nov 19, 1996·270 cites·35 claims
- 0897US5869619AModified antibody variable domainsXOMA CORP·Filed 1993·Granted Feb 9, 1999·462 cites·17 claims
- 0997US5698435AModular assembly of antibody genes, antibodies prepared thereby and useXOMA CORP·Filed 1995·Granted Dec 16, 1997·207 cites·20 claims
- 1097US5595898AModular assembly of antibody genes, antibodies prepared thereby and useXOMA CORP·Filed 1994·Granted Jan 21, 1997·184 cites·4 claims
- 1197US5576184AProduction of chimeric mouse-human antibodies with specificity to human tumor antigensXOMA CORP·Filed 1994·Granted Nov 19, 1996·292 cites·4 claims
- 1296US5846818APectate lyase signal sequenceXOMA CORP·Filed 1995·Granted Dec 8, 1998·182 cites·21 claims
- 1396US5821123AModified antibody variable domainsXOMA CORP·Filed 1995·Granted Oct 13, 1998·146 cites·15 claims
- 1496US5766886AModified antibody variable domainsXOMA CORP·Filed 1992·Granted Jun 16, 1998·1.3k cites·23 claims
- 1595US4489710AComposition and method for transplantation therapyXOMA CORP·Filed 1982·Granted Dec 25, 1984·141 cites·6 claims
- 1694US5770196AModified antibody variable domains and therapeutic uses thereofXOMA CORP·Filed 1995·Granted Jun 23, 1998·122 cites·18 claims
- 1791US5744580AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1995·Granted Apr 28, 1998·57 cites·36 claims
- 1891US5348942ATherapeutic uses of bactericidal/permeability increasing protein productsXOMA CORP·Filed 1993·Granted Sep 20, 1994·100 cites·2 claims
- 1990US5420019AStable bactericidal/permeability-increasing protein muteinsXOMA CORP·Filed 1993·Granted May 30, 1995·59 cites·19 claims
- 2090US5411941AHeterodimeric osteogenic factorXOMA CORP·Filed 1993·Granted May 2, 1995·72 cites·6 claims
- 2190US5093475AHindered linking agents derived from 2-iminothiolanes and methodsXOMA CORP·Filed 1989·Granted Mar 3, 1992·30 cites·48 claims
- 2289US5523288AMethod of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (BPI) protein product and antibioticXOMA CORP·Filed 1994·Granted Jun 4, 1996·77 cites·37 claims
- 2389US5028530AAraB promoters and method of producing polypeptides, including cecropins, by microbiological techniquesXOMA CORP·Filed 1990·Granted Jul 2, 1991·90 cites·14 claims
- 2489US4925922APotentiation of cytotoxic conjugatesXOMA CORP·Filed 1989·Granted May 15, 1990·135 cites·8 claims
- 2588US6255284B1Pharmaceutical compositionXOMA CORP·Filed 2000·Granted Jul 3, 2001·26 cites·8 claims
- 2688US5578572AAnti-gram-positive bacterial methods and materialsXOMA CORP·Filed 1995·Granted Nov 26, 1996·62 cites·13 claims
- 2787US4590071AHuman melanoma specific immunotoxinsXOMA CORP·Filed 1984·Granted May 20, 1986·79 cites·20 claims
- 2886US5621083AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1995·Granted Apr 15, 1997·44 cites·10 claims
- 2985US5484705AMethod for quantifying lipopolysaccharide binding proteinXOMA CORP·Filed 1994·Granted Jan 16, 1996·50 cites·2 claims
- 3085US5447913ATherapeutic uses of bactericidal/permeability-increasing protein dimer productsXOMA CORP·Filed 1994·Granted Sep 5, 1995·41 cites·12 claims
- 3185US4916213ARibosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereofXOMA CORP·Filed 1988·Granted Apr 10, 1990·103 cites·28 claims
- 3284US6146631AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1997·Granted Nov 14, 2000·30 cites·54 claims
- 3384US5837491APolynucleotides encoding gelonin sequencesXOMA CORP·Filed 1994·Granted Nov 17, 1998·55 cites·20 claims
- 3484US5733872ABiologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereofXOMA CORP·Filed 1994·Granted Mar 31, 1998·33 cites·45 claims
- 3584US5488034APharmaceutical composition comprising BPI proteinsXOMA CORP·Filed 1994·Granted Jan 30, 1996·54 cites·6 claims
- 3683US5508263AHeterodimeric osteogenic factorXOMA CORP·Filed 1994·Granted Apr 16, 1996·40 cites·2 claims
- 3783US5416202AMaterials comprising and methods of preparation and use for ribosome-inactivating proteinsXOMA CORP·Filed 1992·Granted May 16, 1995·59 cites·23 claims
- 3882US6599880B1Bactericidal/permeability-increasing protein (BPI) deletion analogsXOMA CORP·Filed 2000·Granted Jul 29, 2003·5 cites·39 claims
- 3982US6107280AAntithrombotic materials and methodsXOMA CORP·Filed 1999·Granted Aug 22, 2000·40 cites·6 claims
- 4082US5783561AAnti-gram-positive bacterial methods and materialsXOMA CORP·Filed 1996·Granted Jul 21, 1998·44 cites·24 claims
- 4182US4698420AAntibody hybrid molecules and process for their preparationXOMA CORP·Filed 1985·Granted Oct 6, 1987·52 cites·16 claims
- 4280US6599881B1Antithrombotic materials and methodsXOMA CORP·Filed 2000·Granted Jul 29, 2003·9 cites·6 claims
- 4379US5639727ATherapeutic uses of bactericidal/permeability increasing protein productsXOMA CORP·Filed 1995·Granted Jun 17, 1997·34 cites·5 claims
- 4479US4664913AMethod for treating plasma for transfusionXOMA CORP·Filed 1984·Granted May 12, 1987·56 cites·8 claims
- 4578US5858974AAnti-fungal peptidesXOMA CORP·Filed 1996·Granted Jan 12, 1999·33 cites·15 claims
- 4677US6268345B1Bactericidal/permeability-increasing protein (BPI) compositionsXOMA CORP·Filed 2000·Granted Jul 31, 2001·3 cites·2 claims
- 4777US5756699AImmunotoxins comprising ribosome-inactivating proteinsXOMA CORP·Filed 1995·Granted May 26, 1998·18 cites·53 claims
- 4877US5439807AMethods for the preparation of endotoxin-binding proteinsXOMA CORP·Filed 1993·Granted Aug 8, 1995·42 cites·6 claims
- 4977US4970303ALinking agents and methodsXOMA CORP·Filed 1988·Granted Nov 13, 1990·12 cites·64 claims
- 5076US5851802AMethods for recombinant microbial production of fusion proteins and BPI-derived peptidesXOMA CORP·Filed 1996·Granted Dec 22, 1998·23 cites·15 claims
Showing the top 50 of 147 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →